Skip to main content
. 2008 Feb 7;111(8):4014–4021. doi: 10.1182/blood-2007-08-106021

Table 1.

Demographic, clinical, and treatment characteristics of 1082 five-year survivors of pediatric non-Hodgkin lymphoma (NHL): Childhood Cancer Survivor Study, North America

No. (%)
Sex
    Male 762 (70)
    Female 320 (30)
Race/ethnicity
    White non-Hispanic 935 (86)
    Black 46 (4)
    Other 95 (9)
    Missing 6 (1)
Age at NHL diagnosis, y
    ≤4 184 (17)
    5-9 326 (30)
    10-14 346 (32)
    15-21 226 (21)
Attained age at death or at close of study, years*
    <20 33 (3)
    20-29 364 (34)
    30-39 518 (48)
    ≥40 165 (15)
NHL histopathology or cell type
    Burkitt/Burkitt-like (9686.3, 9687.3) 245 (23)
    Lymphoblastic (9685.3) and small cell (9670.3, 9672.3) 244 (23)
    Diffuse large cell (9680.3-9684.3, 9592.3, 9593.3) 218 (20)
    Other histopathology or cell types, specified 142 (13)
        Histiocytosis (9720.3, 9723.3) 52 (5)
        Follicular and nodular NHL (9690.3-9698.3) 45 (4)
        Mixed-cell type (9675.3) 10 (1)
        Others (9593.3, 9702.3, 9704.3, 9709.3, 9714.3) 35 (3)
    Unspecified cell type (9590.3, 9591.3) 233 (22)
Stage at NHL diagnosis
    Not metastatic 482 (45)
    Metastatic 268 (25)
    Unknown/missing 332 (31)
Site of primary NHL
    Lymph nodes 523 (48)
    Gastrointestinal tract 109 (10)
    Head and neck, including brain 122 (11)
    Mediastinum or heart 81 (7)
    Bone 52 (5)
    Other sites 140 (13)
    Unknown 55 (5)
Year of NHL diagnosis
    1970-1973 122 (11)
    1974-1977 211 (20)
    1978-1981 311 (29)
    1982-1986 438 (40)
Treatment regimens
    CT, no RT 276 (25)
    RT, no CT 37 (3)
    Both RT and CT 596 (55)
    Neither RT nor CT 12 (1)
    Missing data on either CT or RT 2 (<1)
    Missing all treatment data 159 (15)
Bone marrow transplantation
    No 1033 (95)
    Yes 29 (3)
    Unknown/missing 20 (2)

CT indicates chemotherapy; and RT, radiation therapy.

*

Age as of December 31, 2002, for subjects alive on that date; excludes two with unknown date of death.

By ICD-O-2 code.